IO Biotech, Inc. — Director's Dealing 2023

Nov 17, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IO Biotech, Inc. (IOBT)
CIK: 0001865494
Period of Report: 2023-11-15

Reporting Person: Collins Helen Louise (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-11-15	Stock Option (Right to Buy)	$0.98	A	64238	Acquired	2033-11-15	Common Stock (64238)	Direct

Footnotes

F1: 1/36th of these options vest each month over three years, subject to the reporting person's continued service through each applicable vesting date, and subject to 100% acceleration upon a change of control.